Announced Mon, 26 May · 13:45 IST
Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
Board & Shareholder Meetings View source PDF
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Aurobindo Pharma Limited has submitted a Schedule of Meeting to the Exchange. The specific date, venue, and agenda of the meeting have not been disclosed in this filing. This is a routine regulatory disclosure required before any scheduled investor or board meeting. Further details are likely to follow in subsequent filings.
Likely market impact
This is a routine disclosure with no direct impact on stock price or shareholders. Investors should watch for follow-up filings containing the actual meeting agenda or outcomes.